You don't need to be signed in to listen to BMJ Group Podcasts, but you can register here to receive updates about other BMJ Group products and services via our Group site.

Obesity and heart disease

15 Feb, 11 | by BMJ Group

In this podcast, Alistair Lindsay talks to Jennifer Logue about the link between obesity and heart disease.

Increasing weight is associated with a higher prevalence of known risk factors for coronary artery disease, such as diabetes, high blood pressure and cholesterol. And it has been assumed that these have been responsible for the increased risk of heart disease seen in obesity, say the authors. But now research published in Heart suggests that obesity is a killer in its own right, irrespective of other biological or social risk factors traditionally associated with coronary heart disease.

icon for podpressObesity and heart disease [12:52m]:

Risk of heart failure following unrecognised MI

7 Feb, 11 | by BMJ Group

Alistair Lindsay talks to Maarten Leening (Erasmus MC, The Netherlands) about his research into the risk of heart failure following undiagnosed myocardial infarctions in elderly people.

See also;
Unrecognised myocardial infarction and long-term risk of heart failure in the elderly: the Rotterdam Study

icon for podpressRisk of heart failure following unrecognised MI [13:15m]:

Assessment of reperfusion injury

1 Dec, 10 | by BMJ Group

Alistair Lindsay talks to Declan O’Regan about assessing reperfusion injury using cardiac MRI in patients with acute MI.

See also;
Assessment of severe reperfusion injury with T2* cardiac MRI in patients with acute myocardial infarction

icon for podpressAssessment of reperfusion injury [12:37m]:

Who will benefit from ACE inhibition?

5 Nov, 10 | by BMJ Group

Alistair Lindsay talks to Leong Ng about his work into using biomarkers to identify which groups of patients will benefit from ACE inhibition after acute coronary syndrome.

See also:
Identification of potential outcome benefit from ACE inhibition after acute coronary syndrome: a biomarker approach using N-terminal proBNP

icon for podpressWho will benefit from ACE inhibition? [11:03m]:

Optimal medical therapy and mortality after acute myocardial infarction

5 Nov, 10 | by BMJ Group

In this first edition of the BMJ Heart podcast, Alistair Lindsay talks to Peter Bramlage about his paper on how and when patients are treated after acute myocardial infarction, and the effect optical medical therapy can have on one year mortality.

See also:
The effect of optimal medical therapy on 1-year mortality after acute myocardial infarction

icon for podpressOptical medical therapy and mortality after acute myocardial infarction [13:59m]:

Latest from Heart

Latest from Heart